2-(2-methylphenyl)propan-2-ol - CAS 7572-79-4
Catalog: |
BB059141 |
Product Name: |
2-(2-methylphenyl)propan-2-ol |
CAS: |
7572-79-4 |
Synonyms: |
2-(2-methylphenyl)propan-2-ol; alpha,alpha,2-Trimethylbenzyl alcohol; 2-(2-Methylphenyl)-2-propanol; Dimethyl-o-tolylcarbinol; 2-(o-Tolyl)-2-propanol; 2-(O-tolyl)propan-2-ol |
IUPAC Name: | 2-(2-methylphenyl)propan-2-ol |
Description: | 2-(2-methylphenyl)propan-2-ol (cas# 7572-79-4) is a useful research chemical. |
Molecular Weight: | 150.21 |
Molecular Formula: | C10H14O |
Canonical SMILES: | CC1=CC=CC=C1C(C)(C)O |
InChI: | InChI=1S/C10H14O/c1-8-6-4-5-7-9(8)10(2,3)11/h4-7,11H,1-3H3 |
InChI Key: | UZRCLVBKYONQEI-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021119523-A1 | Use of atr inhibitors in combination with parp inhibitors | 20191211 |
WO-2021012049-A1 | Substituted 2-morpholinopyridine derivatives as atr kinase inhibitors | 20190722 |
TW-202102721-A | Composition, kit, method of treating substrate | 20190705 |
EP-3750897-A1 | Organic electroluminescent materials and devices | 20190610 |
CN-108530400-A | 1- deoxidation bearing taxanes of C-2 and C-4 modifications and preparation method thereof | 20180528 |
CN-108456193-A | The manufacturing method of five thia cycloheptane of 1,2,3,5,6- | 20170221 |
EP-3577115-B1 | Aryl hydrocarbon receptor (ahr) modulator compounds | 20170201 |
EP-3575334-A1 | Molding material and method for producing resin molded body using same | 20170127 |
US-2020270386-A1 | Molding material and method for producing resin molded body using same | 20170127 |
CN-110087627-A | Composition comprising at least two anionic surfactants, nonionic surfactant and amphoteric surfactant and at least one dandruff removing agent | 20161216 |
Complexity: | 129 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 150.104465066 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 150.104465066 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 20.2Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2 |
-
Catalog: BB012200
8-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-chromen-4-one
Detail
-
Catalog: BB054600
3-glycidoxypropyltrimethoxysilane
Detail
-
Catalog: BB016397
1-methyl-3-(1,3-thiazol-2-yl)-1H-pyrazole-5-carbaldehyde
Detail
-
Catalog: BB016437
2-amino-3-{pyrrolo[2,1-f][1,2,4]triazin-5-yl}propanenitrile
Detail
-
Catalog: BB043274
Ethylferrocene
Detail
-
Catalog: BB016398
4-chloro-6-methylimidazo[2,1-f][1,2,4]triazine
Detail
-
Catalog: BB077194
(S)-(-)-1,2-epoxydecane
Detail
-
Catalog: BB000560
6(5H)-Phenanthridinone
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS